Disk diffusion testing using Candida sp. colonies taken directly from CHROMagar Candida medium may decrease time required to obtain results

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3497-3499

  Klevay, Michael ^a   Ebinger, Alex ^a   Diekema, Daniel ^a,c,d   Messer, Shawn ^a   Hollis, Richard ^a   Pfaller, Michael ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; VORICONAZOLE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CULTURE MEDIUM; DRUG SENSITIVITY; FUNGUS CULTURE; FUNGUS ISOLATION; NONHUMAN; PRIORITY JOURNAL;

AGAR; ANTIFUNGAL AGENTS; CANDIDA; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

CANDIDA; SOLANUM TUBEROSUM;

EID: 22144435924     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3497-3499.2005     Document Type: Article

References (5)

1. Hazen, K. C., and S. A. Howell. 2003. Candida, Cryptococcus, and other yeasts of medical importance, p. 1693-1711. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
2. National Committee for Clinical Laboratory Standards. 2004. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline M44-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
3. Pfaller, M. A., D. J. Diekema, R. N. Jones, et al. 2002. Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program. 1997-2000. J. Clin. Microbiol. 40:852-856.
4. Pfaller, M. A., K. C. Hazen, S. A. Messer, et al. 2004. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. J. Clin. Microbiol. 42:3607-3612.
5. Pfaller, M. A., A. Houston, and S. C. Coffmann. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Tondopsis) glabrata. J. Clin. Microbiol. 34:58-61.